Efluelda

Efluelda is a quadrivalent influenza vaccine designed to protect against seasonal flu strains. It contains antigens from influenza A and B viruses, offering broad coverage. Ideal for annual flu prevention, Efluelda is administered via intramuscular or subcutaneous injection.

Efluelda is used to prevent influenza in adults and children. This vaccine targets multiple influenza strains, including Influenza Virus A/Darwin/9/2021 San-010 (H3N2) and Influenza Virus B/Michigan/01/2021. It is typically administered annually to help reduce the risk of flu-related complications.

Common effects of Efluelda may include mild soreness at the injection site, fatigue, and low-grade fever. These effects are usually temporary and resolve within a few days. Severe reactions are rare but possible, and individuals should seek medical attention if they experience persistent symptoms.

Efluelda should be administered by healthcare professionals. Individuals with severe allergies to vaccine components or previous severe reactions to influenza vaccines should consult a healthcare provider before use. Pregnant or breastfeeding women should also seek medical advice before vaccination.

Efluelda may interact with certain medications, including immunosuppressants. It is important to inform healthcare providers about all current medications before receiving the vaccine. Alcohol consumption does not typically affect the vaccine's efficacy but may impact overall health.